Disruption of a Sox9-β-catenin circuit by mutant Fgfr3 in thanatophoric dysplasia type II

Human Molecular Genetics

Volumn 21, Issue 21, 2012, Pages 4628-4644

  Shung, Chia Yi ^a,b   Ota, Sara ^a   Zhou, Zi Qiang ^a   Keene, Douglas R ^a   Hurlin, Peter J ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLUTAMIC ACID; LYSINE; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CHONDRODYSPLASIA; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENCHONDRAL OSSIFICATION; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; GROWTH PLATE; IN VIVO STUDY; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; THANATOPHORIC DWARFISM; THANATOPHORIC DYSPLASIA TYPE 3; VASCULARIZATION;

ANIMALS; BETA CATENIN; CELL DIFFERENTIATION; CHONDROCYTES; GENE EXPRESSION REGULATION; GROWTH PLATE; HUMANS; JOINTS; MICE; MUTATION; OSTEOGENESIS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION; SKULL; SOX9 TRANSCRIPTION FACTOR; THANATOPHORIC DYSPLASIA;

EID: 84867826718     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds305     Document Type: Article

References (51)

1. Dailey, L., Ambrosetti, D., Mansukhani, A. and Basilico, C. (2005) Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev., 16, 233-247.
2. Horton, W.A. and Degnin, C.R. (2009) FGFs in endochondral skeletal development. Trends Endocrinol. Metab., 20, 341-348.
3. Naski, M.C., Wang, Q., Xu, J. and Ornitz, D.M. (1996) Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet., 13, 233-237.
4. Iwata, T., Li, C.L., Deng, C.X. and Francomano, C.A. (2001) Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. Hum. Mol. Genet., 10, 1255-1264.
5. Iwata, T., Chen, L., Li, C., Ovchinnikov, D.A., Behringer, R.R., Francomano, C.A. and Deng, C.X. (2000) A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. Hum. Mol. Genet., 9, 1603-1613.
6. Bi, W., Deng, J.M., Zhang, Z., Behringer, R.R. and de Crombrugghe, B. (1999) Sox9 is required for cartilage formation. Nat. Genet., 22, 85-89.
7. Akiyama, H., Chaboissier, M.-C., Martin, J.F., Schedl, A. and de Crombrugghe, B. (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev., 16, 2813-2828.
8. Hattori, T., Müller, C., Gebhard, S., Bauer, E., Pausch, F., Schlund, B., Bösl, M.R., Hess, A., Surmann-Schmitt, C., von der Mark, H. et al. (2010) SOX9 is a major negative regulator of cartilage vascularization, bone marrow formation and endochondral ossification. Development, 137, 901-911.
9. Ikegami, D., Akiyama, H., Suzuki, A., Nakamura, T., Nakano, T., Yoshikawa, H. and Tsumaki, N. (2011) Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development, 138, 1507-1519.
10. Ng, L.J., Wheatley, S., Muscat, G.E., Conway-Campbell, J., Bowles, J., Wright, E., Bell, D.M., Tam, P.P., Cheah, K.S. and Koopman, P. (1997) SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev. Biol., 183, 108-121.
11. Zhao, Q., Eberspaecher, H., Lefebvre, V. and De Crombrugghe, B. (1997) Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev. Dyn., 209, 377-386.
12. Mackie, E.J., Ahmed, Y.A., Tatarczuch, L., Chen, K.-S. and Mirams, M. (2008) Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int. J. Biochem. Cell Biol., 40, 46-62.
13. Leung, V.Y.L., Gao, B., Leung, K.K.H., Melhado, I.G., Wynn, S.L., Au, T.Y.K., Dung, N.W.F., Lau, J.Y.B., Mak, A.C.Y., Chan, D. et al. (2011) SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet., 7, e1002356.
14. Dy, P., Wang, W., Bhattaram, P., Wang, Q., Wang, L., Ballock, R.T. and Lefebvre, V. (2012) Sox9 directs hypertrophic maturation and blocks osteoblast differentiation of growth plate chondrocytes. Dev. Cell, 22, 597-609.
15. Akiyama, H. and Lefebvre, V. (2011) Unraveling the transcriptional regulatory machinery in chondrogenesis. J. Bone Miner. Metab., 29, 390-395.
16. Clevers, H. (2006) Wnt/beta-catenin signaling in development and disease. Cell, 127, 469-480.
17. Akiyama, H., Lyons, J.P., Mori-Akiyama, Y., Yang, X., Zhang, R., Zhang, Z., Deng, J.M., Taketo, M.M., Nakamura, T., Behringer, R.R. et al. (2004) Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev., 18, 1072-1087.
18. Topol, L., Chen, W., Song, H., Day, T.F. and Yang, Y. (2009) Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. J. Biol. Chem., 284, 3323-3333.
19. Hill, T.P., Taketo, M.M., Birchmeier, W. and Hartmann, C. (2006) Multiple roles of mesenchymal beta-catenin during murine limb patterning. Development, 133, 1219-1229.
20. Day, T.F., Guo, X., Garrett-Beal, L. and Yang, Y. (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell, 8, 739-750.
21. Rodda, S.J. and McMahon, A.P. (2006) Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development, 133, 3231-3244.
22. Kitagaki, J., Iwamoto, M., Liu, J.-G., Tamamura, Y., Pacifci, M. and Enomoto-Iwamoto, M. (2003) Activation of beta-catenin-LEF/TCF signal pathway in chondrocytes stimulates ectopic endochondral ossification. Osteoarthritis Cartilage, 11, 36-43.
23. Mak, K.K., Chen, M.-H., Day, T.F., Chuang, P.-T. and Yang, Y. (2006) Wnt/beta-catenin signaling interacts differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. Development, 133, 3695-3707.
24. Chen, M., Zhu, M., Awad, H., Li, T.-F., Sheu, T.-J., Boyce, B.F., Chen, D. and O'Keefe, R.J. (2008) Inhibition of beta-catenin signaling causes defects in postnatal cartilage development. J. Cell. Sci., 121, 1455-1465.
25. Murakami, S., Kan, M., McKeehan, W.L. and de Crombrugghe, B. (2000) Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc. Natl Acad. Sci. USA, 97, 1113-1118.
26. Logan, M., Martin, J.F., Nagy, A., Lobe, C., Olson, E.N. and Tabin, C.J. (2002) Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer. Genesis, 33, 77-80.
27. Buxton, P., Edwards, C., Archer, C.W. and Francis-West, P. (2001) Growth/differentiation factor-5 (GDF-5) and skeletal development. J. Bone Joint Surg. Am., 83-A (Suppl. 1), S23-S30.
28. Inada, M., Wang, Y., Byrne, M.H., Rahman, M.U., Miyaura, C., López-Otín, C. and Krane, S.M. (2004) Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc. Natl Acad. Sci. USA, 101, 17192-17197.
29. Stickens, D., Behonick, D.J., Ortega, N., Heyer, B., Hartenstein, B., Yu, Y., Fosang, A.J., Schorpp-Kistner, M., Angel, P. and Werb, Z. (2004) Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development, 131, 5883-5895.
30. DasGupta, R. and Fuchs, E. (1999) Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development, 126, 4557-4568.
31. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B. and Kinzler, K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
32. Zhou, Z.-Q., Shung, C.-Y., Ota, S., Akiyama, H., Keene, D.R. and Hurlin, P.J. (2011) Sequential and coordinated actions of c-Myc and N-Myc control appendicular skeletal development. PLoS One, 6, e18795.
33. Wang, Q., Green, R.P., Zhao, G. and Ornitz, D.M. (2001) Differential regulation of endochondral bone growth and joint development by FGFR1 and FGFR3 tyrosine kinase domains. Development, 128, 3867-3876.
34. Guo, X., Day, T.F., Jiang, X., Garrett-Beal, L., Topol, L. and Yang, Y. (2004) Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev., 18, 2404-2417.
35. Yasuhara, R., Ohta, Y., Yuasa, T., Kondo, N., Hoang, T., Addya, S., Fortina, P., Pacifici, M., Iwamoto, M. and Enomoto-Iwamoto, M. (2011) Roles of b-catenin signaling in phenotypic expression and proliferation of articular cartilage superficial zone cells. Lab. Invest., 91, 1739-1752.
36. Facchini, L.M., Chen, S., Marhin, W.W., Lear, J.N. and Penn, L.Z. (1997) The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter. Mol. Cell. Biol., 17, 100-114.
37. Koyama, E., Shibukawa, Y., Nagayama, M., Sugito, H., Young, B., Yuasa, T., Okabe, T., Ochiai, T., Kamiya, N., Rountree, R.B. et al. (2008) A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Dev. Biol., 316, 62-73.
38. Später, D., Hill, T.P., Gruber, M. and Hartmann, C. (2006) Role of canonical Wnt-signalling in joint formation. Eur. Cell Mater., 12, 71-80.
39. Kim, Y., Murao, H., Yamamoto, K., Deng, J.M., Behringer, R.R., Nakamura, T. and Akiyama, H. (2011) Generation of transgenic mice for conditional overexpression of Sox9. J. Bone Miner. Metab., 29, 123-129.
40. Hartmann, C. and Tabin, C.J. (2001) Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell, 104, 341-351.
41. Davies, S.R., Sakano, S., Zhu, Y. and Sandell, L.J. (2002) Distribution of the transcription factors Sox9, AP-2, and DEF1 in adult murine articular and meniscal cartilage and growth plate. J. Histochem. Cytochem., 50, 1059-1065.
42. Kim, I.S., Otto, F., Zabel, B. and Mundlos, S. (1999) Regulation of chondrocyte differentiation by Cbfa1. Mech. Dev., 80, 159-170.
43. Zhou, G., Zheng, Q., Engin, F., Munivez, E., Chen, Y., Sebald, E., Krakow, D. and Lee, B. (2006) Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc. Natl Acad. Sci. USA, 103, 19004-19009.
44. Eswarakumar, V.P., Lax, I. and Schlessinger, J. (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev., 16, 139-149.
45. Ota, S., Zhou, Z.-Q., Link, J.M. and Hurlin, P.J. (2009) The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects. Hum. Mol. Genet., 18, 2609-2621.
46. Hoffmann, A., Czichos, S., Kaps, C., Bächner, D., Mayer, H., Kurkalli, B.G., Zilberman, Y., Turgeman, G., Pelled, G., Gross, G. et al. (2002) The T-box transcription factor brachyury mediates cartilage development in mesenchymal stem cell line C3H10T1/2. J. Cell Sci., 115, 769-781.
47. MacDonald, B.T., Tamai, K. and He, X. (2009) Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev. Cell, 17, 9-26.
48. Farquharson, M., Harvie, R. and McNicol, A.M. (1990) Detection of messenger RNA using a digoxigenin end labelled oligodeoxynucleotide probe. J. Clin. Pathol., 43, 424-428.
49. Carlson, H., Ota, S., Campbell, C.E. and Hurlin, P.J. (2001) A dominant repression domain in Tbx3 mediates transcriptional repression and cell immortalization: relevance to mutations in Tbx3 that cause ulnar-mammary syndrome. Hum. Mol. Genet., 10, 2403-2413.
50. Korinek, V., Barker, N., Willert, K., Molenaar, M., Roose, J., Wagenaar, G., Markman, M., Lamers, W., Destree, O. and Clevers, H. (1998) Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol. Cell. Biol., 18, 1248-1256.
51. Kapeli, K. and Hurlin, P.J. (2011) Differential regulation of N-Myc and c-Myc synthesis, degradation, and transcriptional activity by the Ras/mitogen-activated protein kinase pathway. J. Biol. Chem., 286, 38498-38508.